BioMEANDER (Q3989231): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fix Beneficiary from Netherlands)
(‎Changed an Item: Fix Beneficiary from Netherlands)
Property / beneficiary name (string)
 
Universiteit Twente
Property / beneficiary name (string): Universiteit Twente / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: Q3985142 / rank
 
Normal rank

Revision as of 09:28, 16 December 2021

Project Q3989231 in Netherlands
Language Label Description Also known as
English
BioMEANDER
Project Q3989231 in Netherlands

    Statements

    0 references
    306,823.43 Euro
    0 references
    1,998,722.03 Euro
    0 references
    15.351 percent
    0 references
    1 July 2017
    0 references
    30 June 2020
    0 references
    Lead Pharma Holding
    0 references
    LioniX
    0 references
    Surfix BV
    0 references
    Universiteit Twente
    0 references
    0 references
    0 references
    0 references
    0 references

    51°49'29.71"N, 5°49'23.30"E
    0 references
    6534 AT
    0 references
    7500 AL
    0 references
    6700 AG
    0 references
    7500 AE
    0 references
    Binnen het BioMeander project wordt een zeer gevoelig screening- en detectieplatform, gebaseerd op een asymmetrische Mach-Zehnder interferometer, voor biologische testen ontwikkeld.De gezamenlijke technische innovaties van Surfix en LioniX leide... (Dutch)
    0 references
    Within the BioMeander project, a highly sensitive screening and detection platform, based on an asymmetric Mach-Zehnder interferometer, is being developed for biological testing.The joint technical innovations of Surfix and LioniX... (English)
    15 December 2021
    0 references
    Dans le cadre du projet BioMeander, une plateforme de dépistage et de détection hautement sensible, basée sur un interféromètre Mach-Zehnder asymétrique, est en cours de développement pour les tests biologiques.Les innovations techniques conjointes de Surfix et LioniX... (French)
    15 December 2021
    0 references
    Innerhalb des BioMeander-Projekts wird eine hochempfindliche Screening- und Detektionsplattform, basierend auf einem asymmetrischen Mach-Zehnder-Interferometer, für biologische Tests entwickelt.Die gemeinsamen technischen Innovationen von Surfix und LioniX... (German)
    15 December 2021
    0 references

    Identifiers

    OP-2014-2023-Oost-PROJ-00697
    0 references